MedDataX Logo

The Study to Describe Symptom Control and Impact on Daily Life in Gastroesophageal Reflux Disease (GERD) Patients

NCT ID: NCT01200550

Last Updated: 2012-04-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1233 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-09-30

Study Completion Date

2011-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate symptoms control and impact on daily life from patients perspective using specific GERD Impact Scale(GIS) questionnaire. The another objective is to obtain local epidemiological data for Bosnia and Herzegovina regarding GERD treatment in primary care.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

An Epidemiological Study to Describe Symptom Control and Impact of Gastroesophageal Reflux Disease

NCT01134367

GERD
COMPLETED

Symptom Control and Impact on Daily Life in Patients With Gastroesophageal Reflux Disease

NCT01432392

Gastroesophageal Reflux Disease
COMPLETED

Symptoms and Management Strategies in Gastroesophageal Reflux Disease (GERD)

NCT00768443

Gastroesophageal Reflux Disease
COMPLETED

LIFE NIS, GERD-Patients - Evaluation of Burden of Disease Determined by GERD Impact Scale (GIS)

NCT00567619

GERD
COMPLETED

Impact of GERD on Daily Life (NIS)

NCT00545883

GERD
COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastroesophageal Reflux Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients previously diagnosed with GERD (disease duration =3 years) or newly diagnosed patients that are currently not treated with proton pump inhibitor, for whom specialist or General Practionaire (GP) have previously decided to initiate or change treatment for GERD; Patients should be treated for GERD according to current practice

Exclusion Criteria

* Females of childbearing potential should not be pregnant or nursing
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AstraZeneca

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Srdjan Gornjakovic, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Clinical Center University of Sarajevo; Department of Gastrenterology and HepatologySarajevo

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research Site

Banja Luka, , Bosnia and Herzegovina

Site Status

Research Site

Bijeljina, , Bosnia and Herzegovina

Site Status

Research Site

Derventa, , Bosnia and Herzegovina

Site Status

Research Site

Doboj, , Bosnia and Herzegovina

Site Status

Research Site

Gračanica, , Bosnia and Herzegovina

Site Status

Research Site

Gradačac, , Bosnia and Herzegovina

Site Status

Research Site

Gradiška, , Bosnia and Herzegovina

Site Status

Research Site

Hadžići, , Bosnia and Herzegovina

Site Status

Research Site

Jelah, , Bosnia and Herzegovina

Site Status

Research Site

Laktaši, , Bosnia and Herzegovina

Site Status

Research Site

Lukavac, , Bosnia and Herzegovina

Site Status

Research Site

Lukavica, , Bosnia and Herzegovina

Site Status

Research Site

Matuzići, , Bosnia and Herzegovina

Site Status

Research Site

Mostar, , Bosnia and Herzegovina

Site Status

Research Site

Pale, , Bosnia and Herzegovina

Site Status

Research Site

Prijedor, , Bosnia and Herzegovina

Site Status

Research Site

Sarajevo, , Bosnia and Herzegovina

Site Status

Research Site

Trn, , Bosnia and Herzegovina

Site Status

Research Site

Tuzla, , Bosnia and Herzegovina

Site Status

Research Site

Visoko, , Bosnia and Herzegovina

Site Status

Research Site

Vogošća, , Bosnia and Herzegovina

Site Status

Research Site

Zalužani, , Bosnia and Herzegovina

Site Status

Research Site

Živinice, , Bosnia and Herzegovina

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Bosnia and Herzegovina

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NIS-GBA-DUM-2010/1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Survey to Describe Impact of Reflux Disease on Everyday Life in GERD Patients Before and After 4 Weeks Treatment.
NCT00786773 COMPLETED
Epidemiological Study to Assess the Symptoms and Patterns of Diagnosis and Treatment of GERD
NCT00524355 COMPLETED
Observational Study (This Means That no Drug is Tested) in Patients Suffering of Gastroesophageal Reflux Disease.
NCT01601379 COMPLETED
Prevalence of Gastroesophageal Reflux Disease in Primary Care Patients With Upper Gastrointestinal Symptoms
NCT01020890 COMPLETED
A Cross-sectional Study on the Prevalence and Extraesophageal Symptoms of Gastroesophageal Reflux Disease(GERD) in Patients With Upper GI Symptoms, Visiting the Outpatient Departments of Peripheral Hospitals in Greece
NCT01215305 COMPLETED
Diagnosis and Response to Treatment Using a Reliable Gastroesophageal Reflux Disease (GERD) Questionnaire: An In Clinical Practice Study
NCT00963144 COMPLETED
Canadian, Multi-Centre Study of Symptom Burden and Clinical Management in Subjects With GERD
NCT00634023 COMPLETED
Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms
NCT00703534 COMPLETED PHASE2
Gastroesophageal Reflux Disease in Azerbaijan
NCT03616119 COMPLETED
National Survey on Gastroesophageal Reflux Disease (GERD) Patients
NCT00695838 COMPLETED
Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Tract Symptoms in Egypt
NCT01635959 COMPLETED
Epi-GERD Study: Epidemiological Evaluation in Patients With Gastro-Esophageal Reflux Disease (GERD)
NCT04094402 UNKNOWN
Evaluation Study of a Management Strategy for Gastroesophageal Reflux Disease (GERD)
NCT00842387 COMPLETED
What is the Predictive Value of the Reflux Impact Scale
NCT00536328 TERMINATED
Asociación Española de Gastroenterologia (Spanish Gastroenterology Association) Gastroesophageal Reflux Disease Guideline - Prospective Study
NCT00697008 COMPLETED
Prevalence and Impact in Work Productivity of Gastroesophageal Reflux Disease (GERD) in Primary Care Patients With Upper Gastrointestinal (GI) Symptoms Using GerdQ
NCT00914342 COMPLETED
National Survey on GERD Patients (Adults and Children)
NCT00833573 COMPLETED
Examine National Characteristics & Outcome Measures of GERD Patients Using the PPI Acid Suppression Symptom (PASS) Test for Response
NCT00392002 COMPLETED PHASE4
Correlates of GERD Symptom Severity
NCT03020550 COMPLETED
Prevalence of Gastroesophageal Reflux Disease (GERD) in Patients With Upper Gastrointestinal Track (GIT) Symptoms in Thailand
NCT00999063 COMPLETED
Epidemiological Studies and Risk Factor Analysis of GERD in Xiamen City
NCT06585176 RECRUITING
Structured Treatment of Gastroesophageal Reflux in a Company Health Care Setting, -Effect on Quality of Life, Symptoms and Productivity
NCT00884247 COMPLETED
Association Between Obesity and Gastroesophageal Reflux Disease
NCT07199582 NOT_YET_RECRUITING
Proton Pump Inhibitor Empirical Treatment in Management of Outpatients With Gastroesophageal Reflux Disease.
NCT02606851 COMPLETED
Outcomes for Patients With Gastro-Esophageal Reflux Disease
NCT03824548 UNKNOWN